BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11577375)

  • 1. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
    Seo SK; Regan A; Cihlar T; Lin DC; Boulad F; George D; Prasad VK; Kiehn TE; Polsky B
    Clin Infect Dis; 2001 Nov; 33(9):e105-8. PubMed ID: 11577375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
    Chou S; Miner RC; Drew WL
    J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA
    N Engl J Med; 1997 Jul; 337(2):105-14. PubMed ID: 9211681
    [No Abstract]   [Full Text] [Related]  

  • 4. The changing treatment options for CMV retinitis.
    Gilden D
    GMHC Treat Issues; 1995; 9(7/8):1-8. PubMed ID: 11362648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
    Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
    Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
    Garcia CR; Torriani FJ; Freeman WR
    Ocul Immunol Inflamm; 1998 Sep; 6(3):195-203. PubMed ID: 9785611
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.
    Ducancelle A; Belloc S; Alain S; Scieux C; Malphettes M; Petit F; Brouet JC; Sanson Le Pors MJ; Mazeron MC
    J Clin Virol; 2004 Apr; 29(4):241-7. PubMed ID: 15018851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.
    Julin JE; van Burik JH; Krivit W; Webb C; Holman CJ; Clark HB; Balfour HH
    Transpl Infect Dis; 2002 Dec; 4(4):201-6. PubMed ID: 12535263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
    Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
    Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
    Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
    Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient.
    Okamoto T; Okada M; Mori A; Saheki K; Takatsuka H; Wada H; Tamura A; Fujimori Y; Takemoto Y; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1997 Nov; 20(9):801-3. PubMed ID: 9384487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in the treatment of CMV retinitis.
    Freeman WR
    Ophthalmology; 1996 Jul; 103(7):999-1000. PubMed ID: 8684813
    [No Abstract]   [Full Text] [Related]  

  • 14. New issues in the management of cytomegalovirus retinitis in AIDS patients.
    Pau AK
    Am J Health Syst Pharm; 1998 Feb; 55(4):392-5. PubMed ID: 9504201
    [No Abstract]   [Full Text] [Related]  

  • 15. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of CMV disease in HIV infection.
    Williams IG
    Int J STD AIDS; 1999 Apr; 10(4):211-6; quiz 216-9. PubMed ID: 12035772
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy.
    Holida MD; Trigg ME; Rumelhart SL; Lee NF; Kook H; Peters C
    AIDS; 1995 May; 9(5):531-2. PubMed ID: 7639984
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of CMV infections in HIV-infected patients.
    Hoy J
    Adv Exp Med Biol; 1999; 458():77-87. PubMed ID: 10549381
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus drug resistance.
    Emery VC
    Antivir Ther; 1998; 3(4):239-42. PubMed ID: 10682146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor.
    Castagnola E; Cristina E; Dallorso S; Lanino E; Giacchino R
    J Chemother; 2001 Feb; 13(1):100-1. PubMed ID: 11233794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.